Reply: Comparing highly purified hMG and rFSH in patients undergoing IVF

[1]  P. Devroey,et al.  Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. , 2006, Human reproduction.

[2]  P. Devroey,et al.  Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. , 2006, Human reproduction.

[3]  P. Devroey,et al.  Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. , 2006, Human reproduction.

[4]  J. Collins,et al.  Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review. , 2005, Human reproduction.

[5]  Klaus Diedrich,et al.  The second tier of validation-open discussion and sifting through the evidence: reply of the author , 2003 .

[6]  A. Loft,et al.  A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a 'standard' dose of 150 IU/day in 'standard' patients undergoing IVF/ICSI treatment. , 2003, Human reproduction.

[7]  D. Baird,et al.  A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. , 2003, Fertility and sterility.

[8]  G. Cognigni,et al.  Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. , 2002, Human reproduction.

[9]  L. Westergaard,et al.  Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. , 2001, Fertility and sterility.

[10]  C. Lambalk,et al.  Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study. , 2000, Human reproduction.

[11]  J. Parinaud,et al.  Randomized trial of three luteinizing hormone-releasing hormone analogues used for ovarian stimulation in an in vitro fertilization program. , 1992, Fertility and sterility.

[12]  M. Eijkemans,et al.  Optimum number of oocytes for a successful first IVF treatment cycle. , 2006, Reproductive biomedicine online.